Evidence map›Paper›PMID 39659603›Full record

ArticleRSC advances2024

Molecular docking and

Norah F Alqahtani, Mohammad Y Alfaifi, Ali Shati A, Serag Eldin I Elbehairi, Abdulrahman M Saleh, Ebtesam S Kotb, Waleed M Serag, Reda F M Elshaarawy, Heba W Alhamdi, Yasser A Hassan

RetractedAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Norah F AlqahtaniDepartment of Chemistry, College of Science, University of Jeddah Jeddah 21589 Saudi Arabia.
Mohammad Y AlfaifiKing Khalid University, Faculty of Science, Biology Department Abha 9004 Saudi Arabia.
Ali Shati AKing Khalid University, Faculty of Science, Biology Department Abha 9004 Saudi Arabia.
Serag Eldin I ElbehairiKing Khalid University, Faculty of Science, Biology Department Abha 9004 Saudi Arabia.
Abdulrahman M SalehDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University Kasr El-Aini Street Cairo 11562 Egypt.
Ebtesam S KotbDepartment of Chemistry, Faculty of Science, Suez University 43533 Suez Egypt waleed.ibrahim@suezuniv.edu.eg.
Waleed M SeragDepartment of Chemistry, Faculty of Science, Suez University 43533 Suez Egypt waleed.ibrahim@suezuniv.edu.eg.ORCID https://orcid.org/0000-0002-0136-9307
Reda F M ElshaarawyDepartment of Chemistry, Faculty of Science, Suez University 43533 Suez Egypt waleed.ibrahim@suezuniv.edu.eg.ORCID https://orcid.org/0000-0003-2100-8928
Heba W AlhamdiCollege of Sciences, Biology Department, King Khalid University Abha 61413 Saudi Arabia.
Yasser A HassanDepartment of Pharmaceutics, Faculty of Pharmacy, Delta University for Science and Technology Gamasa Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two new thiadiazole imidazolium salicylidene Schiff bases (TISSBs) were successfully synthesized, and their structures were analyzed comprehensively using spectroscopic techniques. The results of the MTT assay showed that TISSB2 was the safest and most effective anti-breast cancer agent. The anti-angiogenic activity of TISSB2 was evaluated using

Identifiers

PMID39659603
PMCPMC11629753

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.